Immunotherapy at Large: Balancing tumor immunity and inflammatory pathology

Nature Medicine

Volumn 19, Issue 9, 2013, Pages 1100-1101

  Dranoff, Glenn ^a  

^a Cancer Vaccine Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; B RAF KINASE INHIBITOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IPILIMUMAB; LAMBROLIZUMAB; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MONOCLONAL ANTIBODY; NIVOLUMAB; ONCOLYTIC VIRUS; PROGRAMMED DEATH 1 ANTIBODY; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADVANCED CANCER; ADVANCED MELANOMA; ANTINEOPLASTIC ACTIVITY; AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CELL MATURATION; CELL POPULATION; CLINICAL TRIAL (TOPIC); DENDRITIC CELL; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INFLAMMATORY DISEASE; MELANOMA; METASTATIC MELANOMA; NATURAL KILLER CELL; NONHUMAN; NOTE; PATHOLOGY; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TUMOR REGRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; CTLA-4 ANTIGEN; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOTHERAPY; MELANOMA; MICE; PROGRAMMED CELL DEATH 1 RECEPTOR; T-LYMPHOCYTES;

EID: 84883811573     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3335     Document Type: Note

References (16)

1. Elion, G.B. Cancer Res. 45, 2943-2950 (1985).
2. Hamid, O. et al. N. Engl. J. Med. 369, 134-144 (2013).
3. Wolchok, J.D. et al. N. Engl. J. Med. 369, 122-133 (2013).
4. Mellman, I., Coukos, G. & Dranoff, G. Nature 480, 480-489 (2011).
5. Sharma, P., Wagner, K., Wolchok, J.D. & Allison, J.P. Nat. Rev. Cancer 11, 805-812 (2011).
6. Keir, M.E., Butte, M.J., Freeman, G.J. & Sharpe, A.H. Annu. Rev. Immunol. 26, 677-704 (2008).
7. Topalian, S.L. et al. N. Engl. J. Med. 366, 2443-2454 (2012).
8. Dranoff, G. Nat. Rev. Immunol. 12, 61-66 (2011).
9. Vanneman, M. & Dranoff, G. Nat. Rev. Cancer 12, 237-251 (2012).
10. Brahmer, J.R. et al. N. Engl. J. Med. 366, 2455-2465 (2012).
11. Brahmer, J.R. & Pardoll, D.M. Cancer Immunol. Res. 1, 85-91 (2013).
12. Ploegh, H.L. Cancer Immunol. Res. 1, 5-10 (2013).
13. Nowarski, R., Gagliani, N., Huber, S. & Flavell, R.A. Cancer Immunol. Res. 1, 77-84 (2013).
14. Hodi, F.S. et al. J. Clin. Oncol. 31, abstr. CRA9007 (2013).
15. Jinushi, M. et al. J. Clin. Invest. 117, 1902-1913 (2007).
16. Schreiber, R.D., Old, L.J. & Smyth, M.J. Science 331, 1565-1570 (2011).